It is a very exciting time for Hong Kong and this new ATP GMP site is part of that. We want to bring innovative therapy production…
In Conversation
We have no doubts about committing our resources and funds to Belgium ... as we are confident of the environment of broad alignment between authorities, HCPs,…
Ultimately, the goal is to transition from the current acute care business model, where patients primarily seek care in hospitals when they are already in need,…
Being an untapped region, we have many unmet medical needs that are unique to the region such as specific rare diseases
We hope to see more collaboration at the European level which would mitigate the national differences across Europe on patient access to treatments
With COVID’s high demands and the drive for Co2 reductions, the maritime sector is growing in importance within the healthcare supply chain
The complexities of conditions like cancer demand a revolutionary solution. That is where CAR-T cell therapy could be a potential game-changer
The UAE government is extremely open to testing new ideas ... and I hope that we will be able to continue innovating around medical insurance
The patient voice is increasingly recognised as crucial in shaping healthcare policies, and we always strive to amplify those voices
In our efforts to build local capacities, we have set up training centres across Africa, the latest in Egypt, where we are training doctors, operators, and…
Only patients know how a disease truly impacts their lives so they must also speak for change. This is where the idea of a patient-led advocacy…
Frontier markets, particularly in Africa, present great opportunities for setting up facilities for vaccine manufacturing and indeed entire biotech ecosystems
